Point of Care Diagnostics for Emerging Infectious Disease Threats (Market Analysis and Technical Considerations)

552 views

Published on

Within the infectious disease testing market, this report details the opportunities that could be found when diseases of the developing world enter the healthcare system of the developed.

Published in: Health & Medicine, Business
1 Comment
0 Likes
Statistics
Notes
  • Point of care testing (POCT) is a new concept in laboratory medicine that is widely used at present. It is the new advent that helps ease medical care in the present day. The knowledge on the POCT medicine is very important and necessary for the general practitioner. In this specific book, the author summarizes, presents and discusses on the concept of POCT, its importance and examples of important POCT tools.
    eBook: http://amzn.com/B005BYPGJK
    paperback: http://amzn.com/1466256958
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Be the first to like this

No Downloads
Views
Total views
552
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
1
Comments
1
Likes
0
Embeds 0
No embeds

No notes for slide

Point of Care Diagnostics for Emerging Infectious Disease Threats (Market Analysis and Technical Considerations)

  1. 1. Point of Care Diagnostics for Emerging Infectious Disease Threats (MarketAnalysis and Technical Considerations) Pre-PublicationPublished: October 2011No. of Pages: 150Price: $ 2995Because of their ability to deliver fast results at the point of care, rapid testing is a focusarea of healthcare providers and payors in infectious disease prevention. The decentralizedtesting market is experiencing growth faster than the diagnostic markets at large and overthe long term will create opportunities for innovative companies.Kalorama Information has been reporting on the rapid test area for several years and hasidentified the segments with fastest growth, and infectious disease has surfaced as one ofthose segments. This report, Point of Care Diagnostics for Emerging Infectious DiseaseThreats (Market Analysis and Technical Considerations), examines this segment, andespecially new threats for which there are large markets in the developing world and indeveloped countries.Browse All: Pharmaceuticals Market ResearchAn Opportunity For Test MakersInfectious disease is a broad category, and in some disease areas, diagnostic companiesalready own market share. Increasingly hospitals and clinics are seeing new infectiousdisease threats and tests are being developed to assist them. Within the infectious diseasetesting market, this report details the opportunities that could be found when diseases ofthe developing world enter the healthcare system of the developed. This report providesmarket projections for point of care diagnostics in the developed and developing world forthe following infectious diseases: * Chagas Disease, Rapid Test Market Forecast to 2016 * Chikungunya, Rapid Test Market Forecast to 2016 * Dengue Fever, Rapid Test Market Forecast to 2016 * HIV, Rapid Test Market Current Size and Forecast to 2016 * HPV, Rapid Test Market Current Size and Forecast to 2016 * Leishmaniasis, Rapid Test Market Forecast to 2016 * Onchocerciasis (River Blindness), Rapid Test Market Forecast to 2016 * STDs, Rapid Test Market Current Size and Forecast to 2016 * Tuberculosis, Rapid Test Market Forecast to 2016In addition the report also provides: * The Overall Point of Care Diagnostics Market * Economics of Financial and International Programs
  2. 2. * Company Profiles of Leaders in the POC Infectious Disease Market * EMR and Connectivity Issues * Tests in Development * The Role of Drug Resistance * Disease StatisticsTechnical and Market ConsiderationsMany reports provide market projections, but those projections rely on the development ofnew tests which will enter the market. This report considers the technical factors behindproduct development. Tests for diseases can only be provided where the technical means todevelop a test exist. This report also deals with the technical choices, possibilities andlimitations to todays tests. Reagent issues, testing on strips, instrumented and non-instrumented tests. These factors will impact the tests that reach the market.Table Of ContentsCHAPTER ONE: EXECUTIVE SUMMARYScope and MethodologyEmerging Market Trends, diseases and technologiesWorld Demand for Decentralized Testing for Infectious DiseasesCHAPTER TWO: COMMERCIALIZATION OF DECENTRALIZED TEST DEVICES FORINFECTIOUS DISEASESOverviewUser Training and Support ServicesConnectivity Supports Decentralized TestingThe Disease BurdenDrug Resistance Complicates the Test LandscapeAn Unmet NeedEconomics of Financial and International ProgramsConclusionCHAPTER THREE: TECHNICAL CONSIDERATIONSOverviewReagent IssuesInstrumented or non-instrumentedDiagnostics on Paper Test StripsThe Promise of Decentralized Molecular DiagnosticsWireless CommunicationMiniaturizationCHAPTER FOUR: CHAGAS DISEASE
  3. 3. Introduction: Key CommentGeographic MarketsInternational ProgramsStatus quo in testingPlayersTest technologies, now and futureCHAPTER FIVE: CHIKUNGUNYAIntroduction: Key CommentGeographic MarketsInternational ProgramsStatus quo in testingPlayersTest technologies, now and futureCHAPTER SIX: DENGUEIntroduction: Key CommentGeographic MarketsInternational ProgramsStatus quo in testingPlayersTest technologies, now and futureCHAPTER SEVEN: HIVIntroduction: Key CommentGeographic MarketsInternational ProgramsStatus quo in testingPlayersTest technologies, now and futureCHAPTER EIGHT: HPVIntroduction: Key CommentGeographic MarketsInternational ProgramsStatus quo in testingPlayersTest technologies, now and future
  4. 4. CHAPTER NINE: LEISHMANIASISIntroduction: Key CommentGeographic MarketsInternational ProgramsStatus quo in testingPlayersTest technologies, now and futureCHAPTER TEN: LEPTOSPIROSISIntroduction: Key CommentGeographic MarketsInternational ProgramsStatus quo in testingPlayersTest technologies, now and futureCHAPTER ELEVEN: MALARIAIntroduction: Key CommentGeographic MarketsInternational ProgramsStatus quo in testingPlayersTest technologies, now and futureCHAPTER TWELVE: ONCHOCERCIASIS (RIVER BLINDNESS)Introduction: Key CommentGeographic MarketsInternational ProgramsStatus quo in testingPlayersTest technologies, now and futureCHAPTER THIRTEEN: STDsIntroduction: Key CommentGeographic MarketsInternational ProgramsStatus quo in testingPlayersTest technologies, now and future
  5. 5. CHAPTER FOURTEEN: TUBERCULOSISIntroduction: Key CommentGeographic MarketsInternational ProgramsStatus quo in testingPlayersTest technologies, now and futureAbout Us:ReportsnReports is an online library of over 100,000+ market research reports and in-depthmarket research studies & analysis of over 5000 micro markets. We provide 24/7 online andoffline support to our customers. Get in touch with us for your needs of market researchreports.Follow us on Twitter: http://twitter.com/marketsreportsOur Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689Contact:Mr.Priyank7557 Rambler road,Suite727,Dallas,TX75231Tel: + 1 888 391 5441E-mail: sales@reportsandreports.comhttp://www.reportsnreports.comVisit our Market Research Blog

×